An estimated 25 per cent of R&D budgets are now being spent on externalisation, it is crucial to develop strategic and effective business models and determine how best to outsource the different processes of drug discovery.
RECOMMENDED
MSD announces Phase III data on investigational treatment to lower LDL Cholesterol (LDL-C)
2025-11-17
AI for Pharma & Healthcare 2025
2025-06-18
Upcoming Events
DigIT Pharma 2026 | AI Commercial, Medical & Patient Care
September 9 - 10, 2026
Steigenberger Airport Hotel Berlin, Deutschland
Register Now |
View Agenda |
Learn More
Pharmaceutical Launch Excellence Summit US
September 30 - October 1 2026
Hyatt Regency Boston Harbor, Boston, US
Register Now |
View Agenda |
Learn More
SmartLab Exchange Europe
22 - 23 February 2027
Leonardo Royal Hotel Amsterdam, Netherlands
Register Now |
View Agenda |
Learn More